ZEVRA THERAPEUTICS, INC. – Trademark Portfolio
Entity Type: 03
ZEVRA THERAPEUTICS, INC. holds 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 8 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 8 trademarks are registered and 1 is pending. Notable registered marks include ZEVRA, KEMPHARM, KEMPHARM INC, FOCUSEDONATTENTION, and ZEVRA THERAPEUTICS. The owner is based in CELEBRATION, FL.
1180 CELEBRATION BLVD
SUITE 103
CELEBRATION, FL 34747
Showing of trademarks Trademarks
Trademark Classifications
ZEVRA THERAPEUTICS, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does ZEVRA THERAPEUTICS, INC. have?
ZEVRA THERAPEUTICS, INC. has 14 U.S. trademarks filed with the USPTO. Of these, 8 registered, 1 pending, 5 cancelled.
What trademark classes does ZEVRA THERAPEUTICS, INC. file in?
ZEVRA THERAPEUTICS, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.
What are ZEVRA THERAPEUTICS, INC.'s most well-known trademarks?
ZEVRA THERAPEUTICS, INC.'s registered trademark portfolio includes well-known marks such as ZEVRA, KEMPHARM, KEMPHARM INC, FOCUSEDONATTENTION, and ZEVRA THERAPEUTICS. These are among 8 currently registered trademarks in the portfolio.
What is ZEVRA THERAPEUTICS, INC.'s trademark registration success rate?
ZEVRA THERAPEUTICS, INC. has a 62% trademark registration rate, with 8 out of 13 resolved applications resulting in successful registration. Currently, 1 application is pending review.